The Global Breast Biopsy Devices Market was valued at US$ xx million in the year 2018 and is expected to reach US$ xx million by the year 2023, growing at a CAGR of approximately 10.9%. Breast biopsy is the procedure done to obtain tissues or cell samples from the breast. The sample obtained is further tested to check for the presence of cancer. There are 3 types of biopsies, namely core-needle biopsy, fine-needle biopsy, and surgical biopsy.
Fine-needle biopsies are performed when there is a suspicion that the lump is filled with fluid. The fluid from the lump is drawn out and discarded. During a core needle biopsy, a small amount of the suspicious tissue is removed from the breast with the help of a needle that has a larger “core”. Most of the times, specialized imaging equipment are used to guide the needle to the desired site. The various equipment used for this purpose include ultrasound equipment, stereotactic equipment or magnetic resonance.
The major factors that are driving the growth of the Breast Biopsy Devices Industry are the rising incidence of breast cancer, rising number of breast cancer screening programs across the globe, and increasing reimbursement rates in developed countries. The major players in this market are increasingly focussing on launching new and technological advanced products. This is also expected to drive market growth. The breast biopsy wounds and cuts are susceptible to infections if proper care is not taken. This factor may impede the growth of the breast biopsy devices market.
The breast biopsy devices market report covers an in-depth analysis of the market including statistical and subjective data points, along with the key market drivers and opportunities & restraints that have positive or negative effects on the overall global market. An exclusive coverage has been provided for market drivers and challenges & opportunities for a country-level market in the respective regional segments. The report comprises a competitive analysis of the key players functioning in the market and covers in-depth data related to the competitive landscape of the market and the recent strategies & products that will assist or affect the market in the near future.
By Guidance System
By Biopsy Needles
By Needle-based Biopsy Guns
The breast biopsy device market has been segmented into, needle based biopsy guns, biopsy needles, and guidance systems and others. The needle-based biopsy guns segment is further segmented into Fine needle aspiration biopsy devices, vacuum-assisted biopsy devices, and Core needle biopsy devices. The core needle biopsy device segment is expected to dominate the market. Core needle biopsies provide more definitive diagnosis and are less invasive as compared to other types of biopsies.
The biopsy needle segment is further segmented into, disposable biopsy needles and reusable biopsy needles. The market is witnessing an increasing preference of the use of disposable needles over reusable ones. The guidance systems segment is further divided into Ultrasound-guided, Mammography equipment, and Magnetic Resonance. The other devices include, biopsy tables, localization wires, and biopsy forceps, amongst others.
Geographically, North America is dominating the breast biopsy devices market. The major factors responsible for the dominance of this region are the increasing incidence of breast cancer and rising screening programmes in the region. For instance, according the International Agency for Research on Cancer, the number of new breast cancer cases in the US was 234,087 in the year 2018.
The United States Preventive Services Task Force (USPSTF) recommends a mammogram every 2 years to women who are 50 to 74 year old and have an average risk of getting breast cancer. Apart from this, the private group, individual and state Medicaid programs must cover certain breast cancer screening tests at no cost to the consumer. In the year 2015, 52% of women in the age group 40-49 and 72% of the women in the age group of 50-74 had a mammogram in the last 2 years.
The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The rising incidence of breast cancer in countries such as Japan, China, and India is one of the major factors in driving the growth of the breast biopsy devices market in this region. Apart from this, various screening programmes undertaken by the governments in this region are also expected to augment the growth of this market during the forecast period.
Company Profiles:
The major players operating in the global breast biopsy devices market are C.R. Bard Inc (US), Hologic Inc. (US), Argon Medical Devices (US), Beckton Dickinson (US), Cook Medical Inc. (US), Ethicon Endo Surgery (Johnson & Johnson) (US), Devicor Medical Products (US), Encapsule Medical Devices LLC (US), and Intact Medical Corporation (US), amongst others.
The major players are launching new products in the market in order to retain their market share. For instance, in August 2017, Hologic launched a new imaging system for breast biopsy in the United States. The Brevera system can be used for 2D and 3D biopsy. The system will enable fast and efficient procedures that will save the overall cost of the procedure and also enhance patient experience. It enables the collection and imaging of tissue samples within few seconds and can reduce procedure time by about 25%.
Geographies covered:
North America
Europe
Asia Pacific
Rest of the World
Key Questions answered:
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports
Table of Content
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Approach Adopted
1.3.4.1 Top-Down Approach
1.3.4.2 Bottom-Up Approach
1.3.5 Assumptions
1.4 Market Segmentation Scope
Chapter 2 Executive Summary
2.1 Market Summary
2.1.1 Global Breast Biopsy Devices Market, 2016-2023, (US$ Mn)
2.1 Market Snapshot: Global Breast Biopsy Devices Market
2.2 Market Dynamics
2.3 Global Breast Biopsy Devices Market, by Segment, 2018
Global Breast Biopsy Devices Market, by Biopsy Needles, 2018, (US$ Mn)
2.3.1 Global Breast Biopsy Devices Market, by Needle-based biopsy guns, 2018 (US$ Mn)
2.3.2 Global Breast Biopsy Devices Market, by Guidance Systems, 2018 (US$ Mn)
2.3.3 Global Breast Biopsy Devices Market, by Region, 2018 (US$ Mn)
2.4 Premium Insights
2.4.1 Breast Biopsy Devices Market In Developed Vs. Developing Economies, 2018 vs 2023
2.4.2 Global Breast Biopsy Devices Market: Regional Life Cycle Analysis
Chapter 3 Market Dynamics
3.1 Market Overview
3.2 Market Drivers
3.2.1 Increasing Incidence of breast cancer
3.2.2 Rise in the number of breast cancer screening programmes
3.3 Market Restraints
3.3.1 Risk of infection related to breast biopsy procedures
3.4 Market Opportunities
3.4.1 Growth in emerging countries
3.5 Industry SWOT Analysis
Chapter 4 Global Breast Biopsy Devices Market, by Biopsy Needles
4.1 Market Overview, by Biopsy Needles
4.1.1 Global Breast Biopsy Devices Market, by Biopsy Needles, 2016-2023 (US$ Mn)
4.2 Reusable Biopsy Needles
4.2.1 Global Breast Biopsy Devices Market, by Reusable Biopsy Needles, 2016-2023, (US$ Mn)
4.3 Disposable Biopsy Needles
4.3.1 Global Breast Biopsy Devices Market, by Disposable Biopsy Needles, 2016-2023, (US$ Mn)
4.3.2 Incremental Opportunity, by Biopsy Needles, From 2018-2023
Chapter 5 Global Breast Biopsy Devices Market, by Needle-based biopsy guns
5.1 Market Overview, by Needle-based biopsy guns
5.1.1 Global Breast Biopsy Devices Market, by Needle-based biopsy guns, 2016-2023 (US$ Mn)
5.2 Fine needle aspiration biopsy devices
5.2.1 Global Breast Biopsy Devices Market, by Fine needle aspiration biopsy devices, 2016-2023, (US$ Mn)
5.3 Vacuum-assisted biopsy devices
5.3.1 Global Breast Biopsy Devices Market, by Vacuum-assisted biopsy devices, 2016-2023, (US$ Mn)
5.4 Core needle biopsy devices
5.4.1 Global Breast Biopsy Devices Market, by Core needle biopsy devices, 2016-2023, (US$ Mn)
5.4.2 Incremental Opportunity, by Needle-based biopsy devices, From 2018-2023
Chapter 6 Global Breast Biopsy Devices Market, by Guidance systems
6.1 Market Overview, by Guidance systems
6.1.1 Global Breast Biopsy Devices Market, by Guidance systems, 2016-2023 (US$ Mn)
6.2 Ultrasound
6.2.1 Global Breast Biopsy Devices Market, by Ultrasound, 2016-2023, (US$ Mn)
6.3 Mammography equipment
6.3.1 Global Breast Biopsy Devices Market, by Mammography equipment, 2016-2023, (US$ Mn)
6.4 Magnetic Resonance System
6.4.1 Global Breast Biopsy Devices Market, by Magnetic Resonance System, 2016-2023, (US$ Mn)
6.4.2 Incremental Opportunity, by Guidance System, From 2018-2023
6.5 Other Devices
6.5.1 Global Breast Biopsy Devices Market, by Other Devices, 2016-2023, (US$ Mn)
Chapter 7 Global Breast Biopsy Devices Market, by Region
7.1 Market Overview, by Region
7.1.1 Global Breast Biopsy Devices Market, by Region, 2016-2023, (US$ Mn)
7.2 Attractive Investment Opportunity, by Region, 2018
7.3 North America Breast Biopsy Devices Market
7.3.1 North America Breast Biopsy Devices Market, by Product Type, 2016-2023 (US$ Mn)
7.3.2 United States Country Profile
7.3.2.1 United States Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.3.3 Canada Country Profile
7.3.3.1 Canada Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.4 Europe Breast Biopsy Devices Market
7.4.1 Europe Breast Biopsy Devices Market, by Product Type, 2016-2023 (US$ Mn)
7.4.2 United Kingdom Country Profile
7.4.2.1 United Kingdom Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.4.3 Germany Country Profile
7.4.3.1 Germany Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.4.4 France Country Profile
7.4.4.1 France Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.4.5 Italy Country Profile
7.4.5.1 Italy Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.4.6 Spain Country Profile
7.4.6.1 Spain Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.4.7 Rest of Europe
7.4.7.1 Rest of Europe Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.5 Asia Pacific Breast Biopsy Devices Market
7.5.1 Asia Pacific Breast Biopsy Devices Market, by Product Type, 2016-2023 (US$ Mn)
7.5.2 China Country Profile
7.5.2.1 China Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.5.3 Japan Country Profile
7.5.3.1 Japan Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.5.4 India Country Profile
7.5.4.1 India Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.5.5 South Korea Country Profile
7.5.5.1 South Korea Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.5.6 Rest of Asia Pacific
7.5.6.1 Rest of Asia Pacific Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.6 Rest of the World Breast Biopsy Devices Market
7.6.1 Rest of the World Breast Biopsy Devices Market, by Product Type, 2016-2023 (US$ Mn)
7.6.2 Latin America
7.6.2.1 Latin America Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
7.6.3 Middle East & Africa
7.6.3.1 Middle East & Africa Breast Biopsy Devices Market, 2016-2023 (US$ Mn)
Chapter 8 Competitive Intelligence
8.1 Market Players Present in Market Life Cycle
8.2 Top 5 Players Comparison
8.3 Market Positioning of Key Players, 2018
8.4 Market Players Mapping
8.4.1 By Product Type
8.4.2 By Region
8.5 Strategies Adopted by Key Market Players
8.6 Recent Developments in the Market
8.6.1 Mergers & Acquisitions, Partnership, New Product Developments
8.7 Operational Efficiency Comparison by Key Players
Chapter 9 Company Profiles
9.1 C.R. Bard Inc
9.1.1 C.R. Bard Inc Overview
9.1.2 Key Stakeholders/Person in C.R. Bard Inc
9.1.3 C.R. Bard Inc Products Portfolio
9.1.4 C.R. Bard Inc Financial Overview
9.1.5 C.R. Bard Inc News/Recent Developments
9.2 Hologic Inc.
9.2.1 Hologic Inc. Overview
9.2.2 Key Stakeholders/Person in Hologic Inc.
9.2.3 Hologic Inc. Products Portfolio
9.2.4 Hologic Inc. Financial Overview
9.2.5 Hologic Inc. News/Recent Developments
9.3 Argon Medical Devices
9.3.1 Argon Medical Devices Overview
9.3.2 Key Stakeholders/Person in Argon Medical Devices
9.3.3 Argon Medical Devices Products Portfolio
9.3.4 Argon Medical Devices Financial Overview
9.3.5 Argon Medical Devices News/Recent Developments
9.4 Beckton Dickinson
9.4.1 Beckton Dickinson Overview
9.4.2 Key Stakeholders/Person in Beckton Dickinson
9.4.3 Beckton Dickinson Products Portfolio
9.4.4 Beckton Dickinson Financial Overview
9.4.5 Beckton Dickinson News/Recent Developments
9.5 Cook Medical Inc.
9.5.1 Cook Medical Inc. Overview
9.5.2 Key Stakeholders/Person in Cook Medical Inc.
9.5.3 Cook Medical Inc. Products Portfolio
9.5.4 Cook Medical Inc. Financial Overview
9.5.5 Cook Medical Inc. News/Recent Developments
9.6 Ethicon Endo Surgery
9.6.1 Ethicon Endo Surgery Overview
9.6.2 Key Stakeholders/Person in Ethicon Endo Surgery
9.6.3 Ethicon Endo Surgery Products Portfolio
9.6.4 Ethicon Endo Surgery Financial Overview
9.6.5 Ethicon Endo Surgery News/Recent Developments
9.7 Devicor Medical Products
9.7.1 Devicor Medical Products Overview
9.7.2 Key Stakeholders/Person in Devicor Medical Products
9.7.3 Devicor Medical Products Product Portfolio
9.7.4 Devicor Medical Products Financial Overview
9.7.5 Devicor Medical Products News/Recent Developments
9.8 Encapsule Medical Devices LLC
9.8.1 Encapsule Medical Devices LLC Overview
9.8.2 Key Stakeholders/Person in Encapsule Medical Devices LLC
9.8.3 Encapsule Medical Devices LLC Products Portfolio
9.8.4 Encapsule Medical Devices LLC Financial Overview
9.8.5 Encapsule Medical Devices LLC News/Recent Developments
9.9 Intact Medical Corporation
9.9.1 Intact Medical Corporation Overview
9.9.2 Key Stakeholders/Person in Intact Medical Corporation
9.9.3 Intact Medical Corporation Products Portfolio
9.9.4 Intact Medical Corporation Financial Overview
9.9.5 Intact Medical Corporation News/Recent Developments
Log in / Register
